CARD9 antibody | knockout validation | Abcam ab124922

This is a knockout-validated antibody summary, based on the publication "CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: CARD9

Catalog number: ab124922

Summary: Rabbit monoclonal IgG against a synthetic peptide from human CARD9. Reacts with human, mouse and rat. Suitable for western blot and immunohistochemistry (paraffin). Unsuitable for flow cytometry, immunocytochemistry or immunoprecipitation.

Validation Method

Western blot

Sample

Heart tissue and peritoneal macrophages from WT and CARD9−/− mice. Samples were lysed in ice cold RIPA buffer.

Primary incubation

Overnight at 4°C.

Detection

Enhanced chemiluminescence detection solution.

Figure

Western immunoblotting analyses of CARD9 and β-actin (loading control) in mouse heart (A) and macrophages (B) after 5-month normal diet (ND) or high fat diet (HFD) feeding in WT and CARD9−/− mice. Please see Figure 7a,b in the article [1].

References
  1. Cao L, Qin X, Peterson M, Haller S, Wilson K, Hu N, et al. CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity. J Mol Cell Cardiol. 2016;92:185-95 pubmed publisher